Clinical Trial Update: A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma [Phase 1]

View source ↗

Summary

The document reports a Phase 1 study of glofitamab in combination with rituximab plus Ifosfamide, Carboplatin, and Etoposide Phosphate in relapsed/refractory Di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Columvi (glofitamab)
• Etoposide phosphate (etoposide phosphate)
• IFOSFAMIDE (IFOSFAMIDE)
• Rituxan (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 1 | Status: COMPLETED